The association between haemoglobin levels in the first 20 weeks of pregnancy and pregnancy outcomes.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
11
07
2019
accepted:
29
10
2019
entrez:
14
11
2019
pubmed:
14
11
2019
medline:
24
3
2020
Statut:
epublish
Résumé
Low haemoglobin has been linked to adverse pregnancy outcomes. Our study aimed to assess the association of haemoglobin (Hb) in the first 20 weeks of pregnancy, and restoration of low Hb levels, with pregnancy outcomes in Australia. Clinical data for singleton pregnancies from two tertiary public hospitals in New South Wales were extracted for 2011-2015. The relationship between the lowest Hb result in the first 20 weeks of pregnancy and adverse outcomes was determined using adjusted Poisson regression. Those with Hb <110 g/L were classified into 'restored' and 'not restored' based on Hb results from 21 weeks onwards, and risk of adverse outcomes explored with adjusted Poisson regression. Of 31,906 singleton pregnancies, 4.0% had Hb <110 and 10.2% had ≥140 g/L at ≤20 weeks. Women with low Hb had significantly higher risks of postpartum haemorrhage, transfusion, preterm birth, very low birthweight, and having a baby transferred to higher care or stillbirth. High Hb was also associated with higher risks of preterm, very low birthweight, and transfer to higher care/stillbirth. Transfusion was the only outcome where risk decreased with increasing Hb. Risk of transfusion was significantly lower in the 'restored' group compared with the 'not restored' group (OR 0.39, 95% CI 0.22-0.70), but restoration of Hb did not significantly affect the other outcomes measured. Women with both low and high Hb in the first 20 weeks of pregnancy had higher risks of adverse outcomes than those with normal Hb. Restoring Hb after 20 weeks did not improve most adverse outcome rates but did reduce risk of transfusion.
Sections du résumé
BACKGROUND
Low haemoglobin has been linked to adverse pregnancy outcomes. Our study aimed to assess the association of haemoglobin (Hb) in the first 20 weeks of pregnancy, and restoration of low Hb levels, with pregnancy outcomes in Australia.
METHODS
Clinical data for singleton pregnancies from two tertiary public hospitals in New South Wales were extracted for 2011-2015. The relationship between the lowest Hb result in the first 20 weeks of pregnancy and adverse outcomes was determined using adjusted Poisson regression. Those with Hb <110 g/L were classified into 'restored' and 'not restored' based on Hb results from 21 weeks onwards, and risk of adverse outcomes explored with adjusted Poisson regression.
RESULTS
Of 31,906 singleton pregnancies, 4.0% had Hb <110 and 10.2% had ≥140 g/L at ≤20 weeks. Women with low Hb had significantly higher risks of postpartum haemorrhage, transfusion, preterm birth, very low birthweight, and having a baby transferred to higher care or stillbirth. High Hb was also associated with higher risks of preterm, very low birthweight, and transfer to higher care/stillbirth. Transfusion was the only outcome where risk decreased with increasing Hb. Risk of transfusion was significantly lower in the 'restored' group compared with the 'not restored' group (OR 0.39, 95% CI 0.22-0.70), but restoration of Hb did not significantly affect the other outcomes measured.
CONCLUSIONS
Women with both low and high Hb in the first 20 weeks of pregnancy had higher risks of adverse outcomes than those with normal Hb. Restoring Hb after 20 weeks did not improve most adverse outcome rates but did reduce risk of transfusion.
Identifiants
pubmed: 31721799
doi: 10.1371/journal.pone.0225123
pii: PONE-D-19-19488
pmc: PMC6853312
doi:
Substances chimiques
Biomarkers
0
Hemoglobins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0225123Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Clin Nutr. 2016 Jun;35(3):741-7
pubmed: 26070630
Med J Aust. 2012 Sep 3;197(5):291-4
pubmed: 22938128
Am J Clin Nutr. 2000 May;71(5 Suppl):1280S-4S
pubmed: 10799402
Transfus Med. 2018 Feb;28(1):22-39
pubmed: 28722245
J Health Popul Nutr. 2008 Jun;26(2):232-40
pubmed: 18686556
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
Am J Clin Nutr. 2017 Dec;106(Suppl 6):1694S-1702S
pubmed: 29070565
Lancet. 1986 May 3;1(8488):992-5
pubmed: 2871331
Cochrane Database Syst Rev. 2015 Jul 22;(7):CD004736
pubmed: 26198451
J Obstet Gynaecol. 2008 May;28(4):377-81
pubmed: 18604667
Am J Obstet Gynecol. 2015 Oct;213(4 Suppl):S78-90
pubmed: 26428506
Transfusion. 2015 Dec;55(12):2799-806
pubmed: 26246160
Int J Gynaecol Obstet. 2007 Sep;98(3):237-43
pubmed: 17482190
Am J Physiol Regul Integr Comp Physiol. 2009 Nov;297(5):R1477-85
pubmed: 19741055
Ann Hematol. 2006 Sep;85(9):559-65
pubmed: 16691399
Best Pract Res Clin Anaesthesiol. 2013 Mar;27(1):69-84
pubmed: 23590917
Lancet Glob Health. 2013 Jul;1(1):e16-25
pubmed: 25103581
BMC Pregnancy Childbirth. 2016 Jan 25;16:17
pubmed: 26810108
Obstet Gynecol. 2014 Jan;123(1):126-33
pubmed: 24463672
BMC Pregnancy Childbirth. 2009 Nov 27;9:55
pubmed: 19943928
Ann Hematol. 2008 Dec;87(12):949-59
pubmed: 18641987
BMJ. 2013 Jun 21;346:f3443
pubmed: 23794316
ISRN Obstet Gynecol. 2012;2012:368571
pubmed: 22577573